Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: DMS

Market Cap 3.37Cr 3.91Cr 3.1Cr 2.91Cr 5.46Cr 369.41Cr 5.52Cr 37Cr 14Cr 180.9Cr 15Cr 14Cr 625.98Cr P/E Ratio 2026 *
43.3x
P/E Ratio 2027 * 13x
Enterprise Value 4.91Cr 5.7Cr 4.52Cr 4.24Cr 7.96Cr 538.27Cr 8.04Cr 53Cr 21Cr 263.6Cr 21Cr 21Cr 912.13Cr EV / Sales 2026 *
0.86x
EV / Sales 2027 * 0.63x
Free-Float
69.9%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 53 18/07/2022
Director of Finance/CFO - 01/01/2022
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 56 -
Chairman 53 18/07/2022
Director/Board Member 52 16/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 3.91Cr
-2.00%-3.23%-14.29%-19.80% 1.37TCr
+0.69%-1.06%+84.20%+14.73% 507.15Cr
-1.62%+0.41%-40.01%-65.34% 125.32Cr
-2.27%-3.49%-33.37%-43.58% 123.3Cr
+0.59%-5.32%+56.00%+80.38% 116.06Cr
-1.23%+1.53%-41.67% - 98Cr
+5.92%+4.42%+211.61%+211.77% 72Cr
-5.33%-9.08% - - 36Cr
-3.14%+7.27%-59.37%+187.67% 24Cr
Average -0.84%+2.29%+20.39%+52.26% 274.94Cr
Weighted average by Cap. -1.12%+0.50%+12.37%-1.75%

Financials

2026 *2027 *
Net sales 5.68Cr 6.59Cr 5.23Cr 4.9Cr 9.21Cr 622.81Cr 9.3Cr 62Cr 24Cr 305Cr 25Cr 24Cr 1.06TCr 6.59Cr 7.65Cr 6.07Cr 5.69Cr 11Cr 722.6Cr 11Cr 72Cr 28Cr 353.86Cr 29Cr 28Cr 1.22TCr
Net income 8L 9L 7L 7L 12.97L 8.77Cr 13.1L 87.04L 34L 4.3Cr 34.83L 34.09L 15Cr 26L 30.17L 23.93L 22.45L 42.17L 29Cr 42.59L 2.83Cr 1.11Cr 14Cr 1.13Cr 1.11Cr 48Cr
Net Debt 1.54Cr 1.79Cr 1.42Cr 1.33Cr 2.5Cr 168.86Cr 2.52Cr 17Cr 6.55Cr 83Cr 6.71Cr 6.56Cr 286.14Cr 80L 92.82L 73.63L 69.07L 1.3Cr 88Cr 1.31Cr 8.7Cr 3.4Cr 43Cr 3.48Cr 3.41Cr 148.65Cr
Logo DMS
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (49.6%), North and South America (17%), Asia (7.5%), Middle East (7.5%), Africa (3.1%), Oceania (1%) and other (14.3%).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!